Detalhe da pesquisa
1.
Community-engaged basic science in an NCI-designated comprehensive cancer center: antioxidants and chemotherapeutic efficacy.
Cancer Causes Control
; 35(3): 417-427, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37812336
2.
Mesothelioma cancer cells are glutamine addicted and glutamine restriction reduces YAP1 signaling to attenuate tumor formation.
Mol Carcinog
; 62(4): 438-449, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36562471
3.
Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia.
Blood
; 137(6): 751-762, 2021 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32929488
4.
Olanzapine within steroid-sparing antiemetic regimen to prevent chemotherapy-induced nausea and vomiting in patients with acute leukemia receiving multi-day intensive chemotherapy.
J Oncol Pharm Pract
; : 10781552231205824, 2023 Oct 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37817569
5.
Impact of pegaspargase dose capping on incidence of pegaspargase-related adverse events in adults.
J Oncol Pharm Pract
; : 10781552231202217, 2023 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37728166
6.
Arsenic trioxide dose capping to decrease toxicity in the treatment of acute promyelocytic leukemia.
J Oncol Pharm Pract
; 28(6): 1340-1349, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34134554
7.
A Prospective Study of Peritransplant Sorafenib for Patients with FLT3-ITD Acute Myeloid Leukemia Undergoing Allogeneic Transplantation.
Biol Blood Marrow Transplant
; 26(2): 300-306, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31550496
8.
A phase 1 study of the antibody-drug conjugate brentuximab vedotin with re-induction chemotherapy in patients with CD30-expressing relapsed/refractory acute myeloid leukemia.
Cancer
; 126(6): 1264-1273, 2020 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31860140
9.
Peripheral blood blast rate of clearance is an independent predictor of clinical response and outcomes in acute myeloid leukaemia.
Br J Haematol
; 188(6): 881-887, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31804722
10.
Real-world experience managing blinatumomab toxicities in adults with relapsed/refractory acute lymphoblastic leukemia.
J Oncol Pharm Pract
; 26(5): 1080-1085, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31635546
11.
Optimizing pegylated asparaginase use: An institutional guideline for dosing, monitoring, and management.
J Oncol Pharm Pract
; 26(1): 74-92, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30917738
12.
Relapsed Philadelphia Chromosome-Positive Pre-B-ALL after CD19-Directed CAR-T Cell Therapy Successfully Treated with Combination of Blinatumomab and Ponatinib.
Acta Haematol
; 141(2): 107-110, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30695783
13.
Analysis of the Mechanisms of Action of Naphthoquinone-Based Anti-Acute Myeloid Leukemia Chemotherapeutics.
Molecules
; 24(17)2019 Aug 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-31466259
14.
Synthesis, characterization and antineoplastic activity of bis-aziridinyl dimeric naphthoquinone - A novel class of compounds with potent activity against acute myeloid leukemia cells.
Bioorg Med Chem Lett
; 27(1): 6-10, 2017 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27890379
15.
A direct interaction between NQO1 and a chemotherapeutic dimeric naphthoquinone.
BMC Struct Biol
; 16: 1, 2016 Jan 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-26822308
16.
Molecular Pathogenesis and Clinical Significance of Driver Mutations in Primary Myelofibrosis: A Review.
Med Princ Pract
; 25(6): 501-509, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27756071
17.
Mortality and cancer in relation to ABO blood group phenotypes in the Golestan Cohort Study.
BMC Med
; 13: 8, 2015 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25592833
18.
Presence of isocitrate dehydrogenase mutations may predict clinical response to hypomethylating agents in patients with acute myeloid leukemia.
Am J Hematol
; 90(5): E77-9, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25651001
19.
Prospective serial evaluation of 2-hydroxyglutarate, during treatment of newly diagnosed acute myeloid leukemia, to assess disease activity and therapeutic response.
Blood
; 120(23): 4649-52, 2012 Nov 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-23074281
20.
Refractory postallogeneic stem cell transplant pure red cell aplasia in remission after treatment with daratumumab.
Am J Hematol
; 94(8): E216-E219, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31120638